Who We Are
Cullinan Therapeutics is a clinical-stage biotech company developing potential first- or best-in-class, high-impact molecules in autoimmune diseases and cancer, where exceptional scientific expertise, strategic risk-taking, and rigorous decision-making unite to improve peoples’ lives.
We believe in a future where those living with autoimmune diseases and cancer spend less time managing their conditions and more time on what matters most. With a diverse pipeline and deep expertise in immune modulation, Cullinan is where speed meets strategy to move profound innovations forward.
But movement isn’t just about speed — it’s about meaning. Our work is fueled by curiosity, determination, and compassion. We work side by side with our partners across the life science ecosystem to channel our collective potential into improving the lives of people living with autoimmune diseases and cancer.
Cullinan Therapeutics is a clinical-stage biotech company developing potential first- or best-in-class, high-impact molecules in autoimmune diseases and cancer, where exceptional scientific expertise, strategic risk-taking, and rigorous decision-making unite to improve peoples’ lives.
We believe in a future where those living with autoimmune diseases and cancer spend less time managing their conditions and more time on what matters most. With a diverse pipeline and deep expertise in immune modulation, Cullinan is where speed meets strategy to move profound innovations forward.
But movement isn’t just about speed — it’s about meaning. Our work is fueled by curiosity, determination, and compassion. We work side by side with our partners across the life science ecosystem to channel our collective potential into improving the lives of people living with autoimmune diseases and cancer.
“ We don’t just foresee the future, we forge it. At Cullinan Therapeutics, we innovate with intent, pursuing only the most promising molecules for our pipeline to deliver new standards of care for patients.”
OUR LEADERSHIP
